ChengChing Hospital   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Taichung Taiwan

Organization Overview

First Clinical Trial
2006
NCT00434291
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Cheng Ching Hospital, Taichung, Taiwan

Active Ingredients

Drugs in Phase 4 Trials (4)

entecavir (baraclude) (1 trial)

hydrochlorothiazide (esidrix) (1 trial)

lamivudine (epivir) (1 trial)

losartan (cozaar) (1 trial)

Drugs in Phase 2 Trials (1)

nemonoxacin (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Diabetic Foot (Phase 2)

Focal Infection (Phase 2)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hypertension (Phase 4)

Infections (Phase 2)

Pneumonia (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5